Nasdaq:US$15.05 (-0.05) | HKEX:HK$23.55 (-0.20) | AIM:£2.27 (+0.08)
新闻中心及演示文稿
上一篇文章   |   下一篇文章
演示文稿, 科学出版物 | 2010-10-16

ISSX 2011: Preclinical assessment of the absorption, distribution, metabolism and excretion of HMPL-013 (fruquintinib), a novel potent and specific VEGFR inhibitor